Vertex Pharmaceuticals Inc (VRTX)
429.20
+6.42
(+1.52%)
USD |
NASDAQ |
May 13, 15:21
Vertex Pharmaceuticals Price: 429.20 for May 13, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 10, 2024 | 420.67 | 423.32 | 417.50 | 422.78 | 1.064M |
| May 09, 2024 | 419.00 | 421.18 | 416.03 | 418.99 | 676185.0 |
| May 08, 2024 | 413.33 | 425.65 | 412.12 | 418.82 | 1.652M |
| May 07, 2024 | 406.42 | 415.67 | 394.03 | 410.24 | 1.614M |
| May 06, 2024 | 402.77 | 407.59 | 401.02 | 402.50 | 1.464M |
| May 03, 2024 | 401.50 | 405.66 | 397.59 | 401.08 | 1.064M |
| May 02, 2024 | 402.95 | 404.07 | 398.46 | 400.16 | 1.051M |
| May 01, 2024 | 392.81 | 406.95 | 392.47 | 402.14 | 1.256M |
| Apr 30, 2024 | 396.20 | 396.69 | 391.70 | 392.81 | 1.728M |
| Apr 29, 2024 | 397.48 | 399.31 | 394.35 | 396.20 | 604570.0 |
| Apr 26, 2024 | 393.52 | 399.68 | 393.49 | 397.48 | 682467.0 |
| Apr 25, 2024 | 402.44 | 403.88 | 393.00 | 397.70 | 787700.0 |
| Apr 24, 2024 | 404.50 | 406.82 | 399.29 | 400.76 | 806473.0 |
| Apr 23, 2024 | 404.00 | 406.86 | 403.47 | 404.91 | 1.070M |
| Apr 22, 2024 | 397.30 | 406.34 | 396.00 | 399.92 | 1.394M |
| Apr 19, 2024 | 394.72 | 396.98 | 391.25 | 394.28 | 1.342M |
| Apr 18, 2024 | 394.19 | 396.14 | 391.01 | 393.48 | 949091.0 |
| Apr 17, 2024 | 394.94 | 398.11 | 392.03 | 393.10 | 881020.0 |
| Apr 16, 2024 | 396.88 | 398.49 | 392.81 | 394.17 | 695469.0 |
| Apr 15, 2024 | 400.00 | 402.49 | 396.69 | 397.36 | 1.374M |
| Apr 12, 2024 | 396.57 | 400.14 | 393.76 | 396.55 | 1.200M |
| Apr 11, 2024 | 404.30 | 404.69 | 398.85 | 400.23 | 1.060M |
| Apr 10, 2024 | 399.89 | 401.00 | 394.81 | 397.58 | 1.027M |
| Apr 09, 2024 | 406.00 | 406.45 | 399.30 | 404.48 | 727107.0 |
| Apr 08, 2024 | 403.45 | 404.60 | 399.00 | 404.22 | 751935.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
164.61
Minimum
May 13 2019
446.08
Maximum
Jan 30 2024
267.72
Average
262.60
Median
Price Benchmarks
| Amgen Inc | 308.20 |
| Eli Lilly and Co | 758.17 |
| Regeneron Pharmaceuticals Inc | 976.82 |
| Alpine Immune Sciences Inc | 64.94 |
| Editas Medicine Inc | 5.735 |
Price Related Metrics
| PE Ratio | 27.85 |
| PS Ratio | 10.99 |
| PEG Ratio | 1.227 |
| Price to Book Value | 5.972 |
| Price to Free Cash Flow | 32.16 |
| Earnings Yield | 3.59% |
| Market Cap | 110.76B |
| PEGY Ratio | 1.227 |
| Operating PE Ratio | 25.44 |
| Normalized PE Ratio | 26.71 |